dx.doi.org/10.1111/all.13420, hdl.handle.net/1765/105904
Allergy
This work was funded by the European Commission 7th Framework Programme; grant id fp7/601763 - AN INNOVATIVE CAUSAL THERAPY FOR ALLERGY: SAFE AND RAPID INDUCTION OF AN ANTI-INFLAMMATORY IMMUNE RESPONSE USING A MUTANT HYPOALLERGEN AND VITAMIN D3 (BM4SIT)
Department of Internal Medicine

Muraro, A. (A.), Roberts, G, Halken, S, Agache, I. (I.), Angier, E. (E.), Fernandez Rivas, M, … Sheikh, A. (2018). EAACI guidelines on allergen immunotherapy: Executive statement. Allergy, 73(4), 739–743. doi:10.1111/all.13420